Tag Archives: Ulrich von Andrian

Forbes magazine and US science culture

Forbes magazine, which is based in the US but now has editions produced in many countries, describes its focus as business and finance. So, it might seem a little unexpected to find a list of rising stars in the fields of science and health until one remembers the current fascination, worldwide, with innovation which often seems to mean science research which can be commercialized.

Forbes has just published its list of ’30 under 30′ rising stars in the fields of Science and Health Care. Pedro Valencia, who studied with and worked in Robert Langer’s lab at the Massachusetts Institute of Technology (MIT), was one of the 30 cited in the 2012 list. From the Dec. 27, 2012 news item on Azonano,

Valencia was cited for figuring out “how to more quickly synthesize nanoparticles that can be used to make drugs more effective and less toxic and to put multiple drugs inside the same nanotech medicine. This has resulted in many top-notch scientific publications and the formation of a start-up, Blend Therapeutics.”

Valencia was the recipient of the NSF Graduate Fellowship. He was co-advised by Professor Langer and Dr. Omid Farokhzad of the Brigham Women’s Hospital – Harvard Medical School.

Langer and Farokhzad were mentioned in my Oct. 28, 2011 posting about nanotechnology commercialization efforts,

… BIND Biosciences and Selecta Biosciences, two leading nanomedicine companies, announced today that they have entered into investment agreements with RUSNANO, a $10-billion Russian Federation fund that supports high-tech and nanotechnology advances.

RUSNANO is co-investing $25 million in BIND and $25 million in Selecta, for a total RUSNANO investment of $50 million within the total financing rounds of $94.5 million in the two companies combined. …

The proprietary technology platforms of BIND and Selecta originated in laboratories at Harvard Medical School directed by Professor Omid Farokhzad, MD, and in laboratories at MIT directed by Professor Robert Langer, ScD, a renowned scientist who is a recipient of the US National Medal of Science, the highest US honor for scientists, and is an inventor of approximately 850 patents issued or pending worldwide. Drs. Langer and Farokhzad are founders of both companies. [Farokhzad was featured in a recent Canadian Broadcasting Corporation {CBC}, Nature of Things, television episode about nanomedicine, titled More than human.] Professor Ulrich von Andrian, MD, PhD, head of the immunopathology laboratory at Harvard Medical School, is a founder of Selecta.

It is fascinating to observe not only the linkages between business and science/health but also the way in which those linkages contribute to a larger ‘science culture’, which includes science festivals, science-oriented popular culture, science talks for just a few examples.